Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Clinical Trials: Leukemia


A listing of clinical trials currently looking for volunteers to enroll in Leukemia studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama Comprehensive Cancer Center University of Alabama

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Birmingham : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Birmingham : University of Alabama Comprehensive Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Birmingham : University of Alabama at Birmingham

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Birmingham : University of Alabama at Birmingham

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

View More »

Birmingham : University of Alabama, Birmingham

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Birmingham : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Birmingham : University Of Alabama At Birmingham

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Huntsville : Clearview Cancer Institute

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Huntsville : Clearview Cancer Institute

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Huntsville : Clearview Cancer Institute

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Huntsville : Clearview Cancer Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Huntsville : Clearview Cancer Institute

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Huntsville : Clearview Cancer Institute

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Huntsville : TG Therapeutics Investigational Trial Site

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Muscle Shoals : Northwest Alabama Cancer Center, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Muscle Shoals : Northwest Alabama Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Arizona

Phoenix : Phoenix Children'S Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Phoenix :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Phoenix : Phoenix Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Site Reference ID/Investigator# 59324

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

View More »

Scottsdale : Virginia G. Piper Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Scottsdale : Mayo Clinic

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Scottsdale : Call for Information (Investigational Site 0004)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Sedona : Arizona Oncology Associates, PC - NAHOA

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Tucson : Arizona Oncology Associates

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Tucson : Arizona Oncology Associates

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Tucson : University of Arizona (SPORE)

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Tucson : Arizona Oncology Associates, PC - HOPE

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Arkansas

Fayetteville : Highlands Oncology Group

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Hot Springs : Investigational Site Number 840018

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Hot Springs National Park : Genesis Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Jonesboro : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Jonesboro : NEA Baptist Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

View More »

Little Rock : University Of Arkansas For Medical Sciences

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Little Rock : Little Rock Hematology Oncology Associates

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

California

Duarte : City of Hope

An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

Duarte : City of Hope

COG #AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

Duarte : City of Hope

COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Duarte : City of Hope

COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymhoblastic Leukemia (ALL)

Duarte : City of Hope

COG AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)Testing Clofarabine (IND#73789, NSC# 606869) in the Very High Risk Stratum

Duarte : City of Hope

Immune Responses in Acute Leukemia and Chronic Myeloid Leukemia

Duarte : City of Hope

Mechanisms of Response and Resistance to STI571 in CML

Duarte : City of Hope

Molecular Pathogenesis of Acute Leukemia and Myelodysplasia

Duarte : City of Hope

Molecular Pathogenesis of Therapy-Related Leukemia

Duarte : City of Hope

SWOG S0805: Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) with or without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)

Duarte : City of Hope

SWOG S1117: A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

View More »

Anaheim : Pacific Cancer Medical Center, Inc.

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Anaheim : Pacific Cancer Medical Center, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Burbank : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Burbank : East Valley Hematology and Oncology Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Burbank : US Oncology - Providence Health System, Site #167 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Concord : Bay Area Cancer Research Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Duarte : City of Hope

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Duarte : City of Hope

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Duarte : City of Hope

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Duarte : City of Hope National Medical Center

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Duarte : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Escondido : Southwest Cancer Care Medical Group

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Escondido : Southwest Cancer Care Medical Group

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fountain Valley : Robert A. Moss, M.D. FACP, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fountain Valley : Lalita Pandit, MD, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Glendora : Wilshire Oncology Medical Group, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Hayard : Kaiser Permanente Northern California

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

La Jolla : University of California, San Diego - Moores Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

La Jolla : Site Reference ID/Investigator# 48325

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

La Jolla : Site Reference ID/Investigator# 70398

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

La Jolla : Moores UCSD Cancer Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

La Jolla : Univ. of San Diego: Moores UCSD Cancer Center

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

La Jolla : University of California, San Diego/Moores Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California, San Diego- Moores Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

La Jolla : Scripps Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

La Jolla : Scripps Cancer Center

A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

La Jolla : Moores UCSD Cancer Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

La Jolla : Moores Ucsd Cancer Center

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

La Jolla : University of California, San Diego

Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

La Jolla : Danelle James, M.D.

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego, Moores Cancer Center

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego Moores Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

La Jolla : Moores UCSD Cancer Center

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

La Jolla : University of California, San Diego

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

La Jolla : Moores UCSD Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

La Jolla : UCSD Medical Center

Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

La Jolla : Moores UCSD Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Loma Linda : Antranik Agop Bedros

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Long Beach : Jonathan Jaques Children'S Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Long Beach : Miller Children's Hospital Long Beach

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Long Beach : Miller Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Los Angeles : UCLA

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Los Angeles : Childrens Hospital Los Angeles

A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Los Angeles : Children's Hospital of Los Angeles

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Los Angeles : Investigational Site Number 840012

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Los Angeles : UCLA Ronald Reagan Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Los Angeles : Childrens Hospital Los Angeles

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Los Angeles : Childrens Hospital Los Angeles

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Los Angeles : Cedars-Sinai Medical Center

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Los Angeles : UCLA

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Los Angeles : UCLA School of Medicine

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Los Angeles : Metropolitan Hematology Oncology Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Los Angeles : UCLA Division of Hematology-Oncology

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Los Angeles : Ucla-Division Of Hematology/Oncology

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Los Angeles : Cedars-Sinai Medical Center

KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Los Angeles : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Los Angeles : Children'S Hospital Of L.A.

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Los Angeles : Division Of Hematology & Oncology Ctr. For Health Sciences

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

Los Angeles : University of Southern California

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Los Angeles : UCLA Division of Hematology/Oncology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Los Angeles : UCLA

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Los Angeles : University of Southern California

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Los Angeles : Childrens Hospital Los Angeles

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Madera :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Mission Hills : Providence Holy Cross Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Oakland : Oakland Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Oceanside : North County Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Orange : Children's Hospital of Orange County CHOC

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Orange : Children'S Hospital Of Orange County

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Orange : Children's Hospital of Orange County CHOC Cancer Institute

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Orange : Children'S Hospital Of Orange County

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Orange County : Children's Hospital of Orange County

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Oxnard : Ventura County Hematology Oncology Specialists

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Oxnard : Ventura County Hematology Oncology Specialists

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Oxnard : PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Oxnard : Ventura County Hematology Oncology Specialists

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Oxnard : PMK Medical Group, Inc. DBA Ventura

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Palm Springs : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Palo Alto : Stanford University Medical Center Oncology

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Palo Alto : Stanford Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Palo Alto : Stanford Medical Center

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Palo Alto : Stanford Cancer Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Palo Alto : Stanford University Medical Center

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Palo Alto : Lpch & Sumc

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Palo Alto : Stanford Cancer Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Palo Alto : Stanford University Medical Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Poway : Southwest Cancer Care Murrieta

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Rancho Mirage : Cancer and Blood Institute Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Roseville : Kaiser Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Sacramento : Univeristy of California Davis Medical Center

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Sacramento : University of California Comprehensive Cancer Center

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Sacramento : University of California Comprehensive Cancer Center

Phase I Study of Lenalidomide in Patients With Acute Leukemia

Sacramento : University of California Davis

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

San Diego : Kaiser Permanente Medical Group

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

San Diego : Rady Children's Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

San Diego : Moores UCSD Cancer Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

San Diego : Sharp Clinical Oncology Research

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF School of Medicine

A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

San Francisco : University Of California Medical Center

Dasatinib Combo With SMO Inhibitor (BMS-833923)

San Francisco : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

San Francisco : UCSF Helen Diller Family Family Comprehensive Cancer Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

San Francisco : University of California Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

San Francisco : University of California San Francisco

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF School of Medicine

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

San Luis Obispo : (200) Coastal Integrative Cancer Care

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

San Pablo : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Santa Maria : Central Coast Medical Oncology Corp.

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Santa Monica : UCLA Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Santa Monica : UCLA

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Santa Monica, : Sarcoma Oncology Center

Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

Stanford : Stanford Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Stanford : Stanford University School of Medicine

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Stanford : Stanford Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Stanford : (125) University of Stanford

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Stanford : Stanford Cancer Center - Stanford University

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Stanford :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Stanford :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Stanford : Stanford Cancer Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Stanford : Stanford University

A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

Stanford : Stanford University School of Medicine

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford : Stanford University School of Medicine

Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)

Stanford : Stanford University Medical Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Stanford : Stanford University School of Medicine

Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Stanford : Stanford University School of Medicine

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Stanford : Stanford Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Stanford : Stanford University Medical Center Stanford U

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Stanford : Stanford University Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Stanford : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Stanford : Stanford University Medical Center, BMT

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Stockton : St. Teresa Comprehensive Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Vista : Medical Group of North County

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Yorba Linda : St. Jude Heritage Medical Group Virginia Crosson Cancer Center

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Colorado

Aurora : Children'S Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Aurora : (115) University of Colorado Anschultz Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Aurora : Children's Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Aurora : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Aurora :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

View More »

Aurora : Children'S Hospital Colorado

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Aurora : Investigational Site Number 840004

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Boulder : Rocky Mountain Cancer Centers

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Colorado Springs : The Oncology Clinic, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denver : Rocky Mountain Blood and Marrow Transplant Program

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Denver : Rocky Mountain Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Denver : Rocky Mountain Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Denver : Rocky Mountain Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Denver : Rocky Mountain Blood and Marrow Transplant Program

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Denver :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Denver : Rocky Mountain Cancer Centers - Denver

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Denver : Mile High Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denver : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Denver : HCA HealthONE - Rocky Mountain Blood and Marrow Transplant Program

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Connecticut

Hartford : Connecticut Children'S Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Manchester : Medical Oncology and Blood Disorders, LLP

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Britain : The Hospital of Central Connecticut

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

New Haven : Yale Cancer Center

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia

New Haven : Yale Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

View More »

Norwalk : Whittingham Cancer Center at Norwalk Hospital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Norwalk : Norwalk Hospital

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Southington : Cancer Center of Central Connecticut

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Southington : Cancer Center of Central Connecticut

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Southington : Cancer Center of Central Connecticut

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Delaware

Wilmington : A. I. Dupont Hospital For Children

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

District of Columbia

Washington : Georgetown University Medical Center Lombardi Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Washington : Georgetown University Medical Center Lombardi Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Washington :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Washington : Georgetown University

Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Washington : Children'S National Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

View More »

Washington : Georgetown University Hospital

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Washington : George Washington University-Medical Faculty Associates

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Washington : Georgetown University Hospital/Lombardi Cancer Center

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

Florida

Atlantis : Medical Specialists of the Palm Beaches

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Boca Raton : Boca Raton Community Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Boynton Beach : Collaborative Research Group

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Boynton Beach : Collaborative Research Group LLC

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Boynton Beach : Thomas Niederman, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Boynton Beach : University Cancer Institute

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Boynton Beach : Palm Beach Institute of Hematology and Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Boynton Beach : University Cancer Institute, Site #149 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Fort Lauderdale : Holy Cross Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Fort Myers : Florida Cancer Specialists

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Fort Myers : Florida Cancer Specialists

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Fort Myers : Lee Memorial Health System

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Gainsville : University of Florida

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Gainsville : University of Florida

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Hialeah : Palm Springs Research Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Jacksonville : Mayo Clinic Jacksonville

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Jacksonville : Integrated Community Oncology Network

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Jacksonville : Mayo Clinic

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Jacksonville : Nemours Children'S Clinic

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Jacksonville : Integrated Community Oncology Network

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Jacksonville : Baptist Cancer Institute

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Jacksonville : Baptist Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Kissimmee : Osceola Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Lakeland : Watson Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Miami : University of Miami

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Miami :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Miami : Innovative Medical Research of South Florida, Inc.

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Miami : University of Miami Cancer Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Miami Beach : (145) Mount Sinai Comprehensive Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Miami Beach : Mount Sinai Comprehensive Cancer Centers

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

New Port Richey : Florida Cancer Institute

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

New Port Richey : Pasco Hernando Oncology Associates (Kumar)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Port Richey : Pasco Pinellas Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Port Richey : Pasco Hernando Oncology Associates, PA

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Port Richey : Florida Cancer Specialists

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Ocala : Ocala Oncology Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Ocoee : Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Orlando : Md Anderson Cancer Center Orlando

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Orlando : Nemours Children'S Clinic - Orlando

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Orlando : Cancer Centers of Florida

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Pembroke Pines : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pensacola : Investigational Site Number 840016

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Pensacola : Woodlands Medical Specialists

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Sarasota :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

St. Petersburg : Florida Cancer Specialists

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

St. Petersburg : Florida Cancer Specialists

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

St. Petersburg : All Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

St. Petersburgh : All Children's Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Stuart : Martin Memorial Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Tampa : H. Lee Moffitt Cancer Center & Research Institute

CNDO-109-AANK for AML in First Complete Remission (CR1)

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Tampa : Moffitt Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Tampa : Call for Information (Investigational Site 0006)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Tampa : H. Lee Moffitt Cancer Center

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Tampa : Moffitt Cancer Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Tavares : Lake County Oncology and Hematology

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Tavares : Lake County Oncology and Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Titusville : Space Coast Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

West Palm Beach : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Weston : Cleveland Clinic Florida

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Weston : Cleveland Clinic Florida

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Georgia

Albany : Phoebe Putney Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta : Emory University, Winship Cancer Institute

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Atlanta : Aflac Cancer Center & Blood Disorders Service

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Atlanta : Emory University, Winship Cancer Institute

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Atlanta : Emory University, Winship Cancer Institute

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

View More »

Atlanta : Blood and Marrow Transplant Group of Georgia

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Atlanta : Winship Cancer Institute, Emory University

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Atlanta : Northside Hospital/BMTGA

A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

Atlanta : Site Reference ID/Investigator# 26523

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Atlanta : Winship Cancer Institute of Emory University

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Atlanta : Georgia Cancer Specialists

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta : Peachtree Hematology-Oncology Consultants

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Atlanta : Winship Cancer Institute

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Atlanta : Emory University Winship Cancer Institute

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Atlanta : Emory University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Atlanta : Children's Healthcare of Atlanta, Emory University

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Augusta : Investigational Site Number 840006

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Augusta : Georgia Health Sciences University

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Augusta : Augusta Oncology Associates, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Augusta : For additional information regarding sites for this trial call (919) 465-4648

Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia

Augusta : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Augusta : Investigational Site Number 840006

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Augusta : Georgia Health Sciences University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dublin : US Oncology - Dublin Hematology & Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Griffin : Spalding Oncology Services

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Marietta :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Marietta : Northwest Georgia Oncology Centers, PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Sandy Springs : Georgia Cancer Specialist

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Savannah : Lewis Cancer Center and Research Pavilion

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Hawaii

Honolulu : Straub Clinic and Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Honolulu : OnCare

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Honolulu : Straub Clinical & Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Idaho

Boise : St Luke's Mountain States Tumor Institute

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Post Falls : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Illinois

Elgin : Sherman Health

E2906 - Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age>/=60 Years

Elgin : Sherman Health

ECOG E2903 Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed By Campath-1H For Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia

Elgin : Sherman Health

S0919 - Phase II A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)

View More »

Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Chicago : Site Reference ID/Investigator# 71593

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chicago : University of Chicago

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Chicago : Northwestern University Fienberg School of Medicine

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Chicago : Children'S Memorial Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Chicago : Northwestern University

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Participants With Acute Leukemia

Chicago : Northwestern University

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Chicago : Children's Memorial Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Chicago : Northwestern Memorial Hospital

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Chicago : The University of Chicago Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Chicago : Rush University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago SC

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Chicago : Northwestern University

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Chicago : Northwestern University

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Chicago : Northwestern University

Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

Chicago : Northwestern University

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Chicago : University of Chicago

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Chicago : 1315.1.1003 Boehringer Ingelheim Investigational Site

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

Chicago : University of Chicago

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Chicago : University of Chicago

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Chicago : John H. Stroger, Jr., Hospital of Cook County

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Rush University Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Northwestern University Feinberg School of Medicine

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : Rush University Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : University of Chicago Cancer Research Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : Northwestern University

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Chicago : Robert H. Lurie Comprehensive Cancer Center Northwestern University

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Chicago : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Chicago : Children'S Hospital Of Chicago

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Chicago : Northwestern University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chicago : University of Chicago, Site #001 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Chicago : Rush University Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Chicago : University of Chicago Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Chicago : Children's Memorial Hospital

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Chicago : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Chicago : Northwestern University

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Chicago : University of Chicago Cancer Center

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Chicago : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Chicago : Univerity of Chicago

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Chicago : University of Chicago Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Chicago : Rush University Medical Center, Division of Hematology/Oncology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chicago : University of Chicago

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chicago : Northwestern University

Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

Evanston : North Shore Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Evergreen Park : Mahafzah Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gurnee : Oncology Hematology Assoc. of Northern Illinois

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Harvey : Ingalls Cancer Research Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Hines : Edward Hines Jr. VA Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Lombard : Elmhurst Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Maywood : Investigational Site Number 840011

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Maywood : Cardinal Bernardin Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Maywood : Loyola University Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Niles : Oncology Specialists, S.C.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Niles : Orchard Health Care Research

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Normal : Mid-Illinois Hem/Onc Asoc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

North Chicago : North Chicago VA Medical Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

North Chicago : North Chicago VA Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

North Chicago : North Chicago VA Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Peoria : Illinois Cancer Care

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Skokie : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Skokie : Hematology Oncology Assoc. of IL.

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Skokie : Orchard Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Skokie : Edward H. Kaplan MD & Associates

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Springfield : Southern Illinois University School Of Medicine

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Springfield : Southern Illinois School of Medicine

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Urbana : Carle Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Indiana

Anderson : Saint John's Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Beech Grove : St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Beech Grove : St. Francis Cancer Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Beech Grove : Indiana Blood and Marrow Transplantation, LLC

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Goshen :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

View More »

Goshen : Center for Cancer Care @ Goshen Health Systems

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Indianapolis : Indiana University Riley Hospital for Children

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Indianapolis :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialits

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Indianapolis : Indiana University Simon Cancer Center IU Simon Cancer Center Clinical Research Office, RT 380

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Indianapolis : Indiana University Cancer Center Clinical Research Office

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Indianapolis : Indiana Oncology Hematology Consultants

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Indianapolis : James Whitcomb Riley Hospital For Children

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Indianapolis : Children'S Center For Cancer And Blood Diseases

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype

Indianapolis : Franciscan St. Francis Health

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Indianapolis : Franciscan St. Francis Health, Site #138 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Indianapolis : Indiana University Simon Cancer Center

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Indianapolis : Indiana Blood and Marrow Transplantation

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Indianapolis : Investigative Clinical Research of Indiana

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lafayette : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Lafayette : Arnett Cancer Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Lafayette : Horizon Oncology Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Mishawaka : Cancer Care Partners, LLC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Albany : Cancer Care Center, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Albany : Cancer Care Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Albany : Cancer Care Center, Inc. PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Iowa

Ames : McFarland Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bettendorf : Hematology Oncology Associates of the Quad Cities

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cedar Rapids : Iowa Blood and Cancer Care of PCI

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Iowa city : University of Iowa Hospitals and Clinics

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Iowa City : University of Iowa Hospitals and Clinics

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

View More »

Mason City : N. Iowa Mercy Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Waterloo : Covenant Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kansas

Hutchinson : Hutchinson Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Kansas City : Investigational Site Number 840010

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Kansas City : University of Kansas Medical Center

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Kansas City : University of Kansas Medical Center, Westwood Campus

Safety Study: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

Kansas City : University of Kansas Medical Center

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

View More »

Topeka : Cotton O'Neil Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Westwood : University of Kansas Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Westwood : University of Kansas Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Wichita : Cancer Center of Kansas, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wichita : US Oncology - Cancer Center of Kansas, Site #168 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Wichita : Cancer Center of Kansas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Witchita : Cancer Center of Kansas

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Kentucky

Hazard : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Hazard : Kentucky Cancer Clinic

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Lexington : Investigational Site Number 840013

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Lexington : Central Baptist Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Louisville : (175) University of Kentucky, Lousiville James Graham Brown Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

View More »

Louisville :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Paducah :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Paducah : Investigational Site Number 840007

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Paducah : Purchase Cancer Group

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Louisiana

Baton Rouge : Mary Bird Perkins Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Baton Rouge : Mary Bird Perkins Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Marrero :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Metairie : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

New Orleans : (195) Tulane University Hospital Tulane Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

View More »

New Orleans : Ochsner Medical Institutions

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

New Orleans : Tulane University Health Sciences Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

New Orleans : Ochsner Clinic Foundation

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Shreveport : Willis-Knighton Cancer System

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Maryland

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia

Baltimore : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Baltimore : Sidney Kimmel Cancer Center at Johns Hopkins

A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission

Baltimore : John Hopkins

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Baltimore :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

View More »

Baltimore : University of Maryland Greenbaum Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Baltimore : Johns Hopkins Medical Institute

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Baltimore : John Hopkins University

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Baltimore : University of Maryland Greenebaum Cancer Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Baltimore : Sidney Kimmel Cancer Center At Johns Hopkins

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Baltimore :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Baltimore : Auerbach Hematology Oncology Associates, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : Greater Baltimore Medical Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : Chesapeake Oncology Hematology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Baltimore : B. Douglas Smith, M.D.

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Baltimore : Johns Hopkins Kimmel Cancer Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Baltimore : Johns Hopkins University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Baltimore : Greater Baltimore Medical Center, Site #140 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Baltimore : Johns Hopkins Hospital

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Baltimore : University of Maryland Greenebaum Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : Sidney Kimmel Comprehensive Cancer Center

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : Call for Information (Investigational Site 0001)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Baltimore : Johns Hopkins University

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Bethesda : Research Site

A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia

Bethesda : Center for Cancer & Blood Disorders, PC

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Bethesda : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Bethesda : Center for Cancer and Blood Disorders

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Columbia : Maryland Oncology Hematology Pa

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Cumberland : Western Maryland Health System, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Westminster : Alliance Hematology Oncology, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Massachusetts

Boston : Site Reference ID/Investigator# 48324

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Boston : Dana-Farber Cancer Institute

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Boston : Dana-Farber Cancer Institute

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Boston : Dana Farber Cancer Institute

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Boston : Investigational Site Number 840004

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

View More »

Boston : Investigational Site Number 840104

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Boston :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Boston : Dana Farber Cancer Institute Deptof DanaFarberCancerInst(4)

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Boston : Dana-Farber Cancer Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Boston : Tufts University School of Medicine-Tufts Medical Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Boston : Beth Israel Deaconess Medical Center

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)

Boston : Beth Israel Deaconess Medical Center

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

Boston : Dana-Farber Cancer Institute

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Boston : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Boston : Dana Farber Institute

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Boston : Dana Farber Cancer Institute and Children's Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Boston : Dana Farber Cancer Institute

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Boston : Beth Israel Deaconess Medical Center

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Boston : Dana-Farber Cancer Institute

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Boston : Massachusetts General Hospital

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Boston :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Boston : Dana Farber Cancer Institute

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Boston : Dana-Farber Cancer Institute

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Boston : Dana Farber Cancer Institute

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Boston : Dana-Farber Cancer Institute

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Boston : Dana Farber Cancer Institute

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Boston : Dana Farber Cancer Institute

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Boston : Dana Farber Cancer Institute

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Boston : Dana Farber Cancer Institute, Site #008 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Boston : Dana-Farber Cancer Institute

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Boston : Beth Israel Deaconess Medical Center

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Boston : Massachusetts General Hospital

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Boston : Dana Farber Cancer Institute Ctr. for Hematologic Oncology

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Boston : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Boston : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Boston : Brigham & Women's Hospital

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Boston : Dana Farber Cancer Institute

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Boston : Beth Israel Deaconess Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Dana-Farber Cancer Institute

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Massachusetts General Hospital

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Dana Farber Cancer Institute

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Boston : Boston VA Healthcare System

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Boston : Beth Israel Deaconess Medical Center

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Dana-Farber Cancer Institute

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Massachusetts General Hospital

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Dana Farber Cancer Institute

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Boston : Dana Farber

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Hyannis : Capecod Hospital / Davenport Mugar Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Quincy : Commonwealth Hematology-Oncology, P.C.

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Wocester :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Worcester : Fallon Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Worcester : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Worcester : University of Massachusetts Memorial Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Michigan

Ann Arbor :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Ann Arbor : University Of Michigan Health System

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Ann Arbor : University of Michigan Comprehensive Cancer Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Cancer Center

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Ann Arbor : University of Michigan Comprehensive Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

View More »

Ann Arbor : University of Michigan Health System

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Ann Arbor : University of Michigan

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Ann Arbor : C.S. Mott Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Detroit : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Detroit : Karmanos Cancer Institute

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Detroit : Karmanos Cancer Institute

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Detroit : Karmanos Cancer Institute

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Detroit : Henry Ford Health System

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Detroit : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Detroit : Barbara Ann Karmanos Cancer Institute

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Detroit : Children's Hospital of Michigan

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Detroit : Henry Ford Hospital

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Detroit : Children'S Hospital Of Michigan

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Detroit : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Detroit : Henry Ford Health System

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Farmington Hills : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Flint : Michigan State University / McLaren Regional Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Flint : Genesee Cancer & Blood Disease Treatment Center, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Freesoil : West Michigan Regional Cancer & Blood Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Grand Rapids : Cancer and Hematology Centers of Western Michigan

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Grand Rapids : Spectrum Health Hospitals

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Kalamazoo : West Michigan Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kalamazoo : West Michigan Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lansing : Michigan State University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Minneapolis : University of Minnesota

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Southfield : Providence Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Minnesota

Duluth : Duluth Clinic Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Minneapolis : University of Minnesota

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Minneapolis : Minnesota Oncology Hematology, PA

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Minneapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Participants With Acute Leukemia

Minneapolis : Children's Hospital and Clinics of Minnesota

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

View More »

Minneapolis : University of Minnesota

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Minneapolis : Masonic Cancer Center, University if Minnesota

Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Minneapolis : Minnesota Oncology Hematology P.A.

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Minneapolis : Novartis Investigative Site

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Minneapolis : University of Minnesota

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Minneapolis : Division of Hematology, Oncology and Transplantation University of Minnesota

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Minneapolis : University of Minnesota Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Minneapolis : Childrens Hospital & Clinics of Minnesota

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Rochester : Mayo Clinic

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Rochester : Mayo Clinic

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Rochester : Mayo Clinic

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Rochester : Mayo Clinic

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Rochester : Mayo Clinic

Clinical Study of PM01183 in Patients With Acute Leukemia

Rochester : Mayo Clinic

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Rochester :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Rochester : Mayo Clinic

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Rochester : Mayo Clinic

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

St. Louis Park : Park Nicollet Institute Metro - MN CCOP

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis Park : Park Nicollet Institute - Louisiana Ave.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Mississippi

Jackson : Univ Of Mississippi Med Ctr

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Missouri

Branson : Branson Oncology Clinic

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Columbia : US Oncology - Missouri Cancer Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbia : Ellis Fischel Cancer Center, University of Missouri Health Care

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Jefferson City : Capitol Comprehensive Cancer Care Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kansas City : Saint Luke's Cancer Institute

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

View More »

Kansas City : The Children'S Mercy Hospital And Clinics

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Springfield : St. John's Medical Research Institute

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Springfield : Mercy Clinic - Cancer & Hematology, Site #151 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Springfield : St John's Clinic for Cancer and Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

St Louis : Investigational Site Number 840015

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

St Louis : Washington University at St Louis

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

St. Joseph : St. Joseph Oncology, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis : Washington University School of Medicine

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

St. Louis : (100) Washington University School of Medicine

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

St. Louis :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Louis : St. Louis University Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

St. Louis : St. Louis University Cancer Center

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

St. Louis : Washington University School of Medicine

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

St. Louis : 1315.1.1004 Boehringer Ingelheim Investigational Site

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

St. Louis : Washington University School of Medicine

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

St. Louis : St. Louis University Cancer Center

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

St. Louis : Hematology Oncology Consultants, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis : St. Louis Hematology Oncology Specialists, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

St. Louis : Washington University Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

St. Louis : Washington University at St. Louis Siteman Cancer Center

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

St. Louis : Washington University School of Medicine

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Montana

Billings : Call for Information (Investigational Site 0003)

A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)

Billings : (150) Billings Clinic

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Billings : Billings Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Missoula : Montana Cancer Institute Foundation

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Nebraska

Lincoln : Nebraska Hematology Oncology, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lincoln : Nebraska Hematology-Oncology, P.C., Site # 133 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Omaha : Nebraska Medical Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Omaha : University of Nebraska Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

View More »

Omaha : University of Nebraska Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Omaha : University of Nebraska Medical Center

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Omaha : University of Nebraska Medical Center University of Nebraska Med Ctr

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Omaha : University of Nebraska Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Omaha : University of Nebraska Medical Center

Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma

Omaha : Omaha VAMC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Nevada

Carson City : Sierra Nevada Oncology Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Henderson : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Las Vegas : Southern Nevada Cancer Research Foundation

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Las Vegas : Nevada Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Las Vegas : Children'S Specialty Center Of Nevada

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

View More »

Las Vegas : US Oncology - Comprehensive Cancer Center of Nevada, Site #169 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Las Vegas : Nevada Cancer Research Foundation

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Reno : VA Sierra Nevada Healthcare System

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Hampshire

Lebanon : Investigational Site Number 840017

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Lebanon : Dartmouth - Hitchcock Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Lebanon : Dartmouth-Hitchcock Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Portsmouth : Portsmouth Regional Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Jersey

Cherry Hill : The Center for Cancer and Hematologic Disease

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cherry Hill : The Center for Cancer and Hematologic Disease

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denville : Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A.

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Elizabeth : Ellioth Fishkin, MD

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Englewood : Drs. Forte, Schleider, Attas & Condemi, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Hackensack : Hackensack University Medical Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Hackensack : Hackensack University Medical Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Hackensack : Hackensack University Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Hackensack : Hackensack University Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Hackensack :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hackensack : John Theurer Cancer Center at the Hackensack University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Hackensack :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Hackensack : Pfizer Investigational Site

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Hackensack : Hackensack University Medical Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Hackensack : Research Site

AMG 319 Lymphoid Malignancy FIH

Hackensack : Hackensack University Medical Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Hackensack : Hackensack University Medical Center Dept.of HackensackUniv.MedCtr.

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Hackensack : The Cancer Center at Hackensack University Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Hackensack : Hackensack University Medical Center

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Hackensack : Hackensack University Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Hackensack : John Theurer Cancer Center at HackensackUMC

Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance

Hackensack : John Theurer Cancer Center, Site #128 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Hackensack : Hackensack University Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Hackensack : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Hackensack : John Theurer Cancer Center

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hackensack : Hackensack University Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Morristown : Hematology Oncology Associates of Northern New Jersey

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Morristown : Hematology Oncology Associates of Northern New Jersey

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Morristown : Hematology Oncology Associates of Northern New Jersey

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Morristown : Hematology Oncology Associates of Northern New Jersey PA Dept of Hem-Onc of Northern NJ

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Morristown : Charles Farber, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Morristown : Hematology Oncology of Northern New Jersey

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Morristown : Goryeb Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Morristown : Hematology-Oncology Associates of Northern NJ, PA

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Brunswick : UMDNJ/Robert Wood Johnson

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

New Brunswick : Investigational Site Number 840001

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Paterson : St. Joseph'S Regional Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Somerville : Steeplechase Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Somerville : Somerset Hematology Oncology Associates

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Summit : Overlook Hospital

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Vineland : Southern Oncology Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New York

Albany : New York Oncology Hematology, P.C.

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Albany : Samuel S Stratton VAMC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bay Shore : Hematology Oncology Associates of Western Suffolk

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Children's Hospital at Montefiore

A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer

Bronx : Montifiore Medical Center

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

View More »

Bronx : Bronx River Medical Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Eastchester Center for Cancer Care

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Albert Einstein College of Medicine

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bronx : Montefiore Medical Center

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Bronx : Montefiore Medical Center / AECOM

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Bronxville : Eduardo Saponara, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Buffalo : Roswell Park Cancer Institute

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Buffalo : Roswell Park Cancer Institute

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

Buffalo :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Buffalo : Roswell Park Cancer Streets

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Buffalo : Jonah Cancer Care Center & ECMC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Buffalo : Roswell Park Cancer Institiute

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Buffalo : Roswell Park Cancer Institute

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Buffalo : Roswell Park Cancer Institute

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Buffalo : Roswell Park Cancer Institute

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Buffalo : Roswell Park Cancer Institute

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Dunkirk :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hawthorne : Westchester Hematology Oncology Group, PC

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Hawthorne : New York Medical College

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Johnson City : Broome Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Johnson City : Broome Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lake Success : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Lake Success : North Shore - LIJ Health System

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Lake Success : North Shore Long Island Jewish Health System

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Mount Kisco : Westchester Hematology Oncology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Hyde Park : Long Island Jewish Medical Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

New Hyde Park : Site Reference ID/Investigator# 71813

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

New Hyde Park : CLL Research and Treatment Program

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

New Hyde Park : North Shore University Hospital

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

New Hyde Park : Long Island Jewish Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

New Hyde Park : Long Island Jewish Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

New Hyde Park : Long Island Jewish Medical Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

New Hyde Park : Long Island Jewish medical Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

New Hyde Park :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

New Hyde Park : Long Island Jewish Medical Center

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

New Hyde Park : Long Island Jewish Medical Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

New York : Memorial Sloan Kettering Cancer Center

A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene

New York : Weill Cornell Medical College

A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)

New York : Site Reference ID/Investigator# 56810

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

New York : New York Presbyterian Hospital/ Cornell Medical Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

New York : Stephen D. Hassenfeld Children'S Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

New York : Weill Cornell Medical College

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

New York : Memorial Sloan Kettering Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

New York : Mount Sinai Medical Center

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

New York : Weill Cornell Medical College

A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission

New York : Memorial Sloan Kettering Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

New York : Beth Israel Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

New York : Memorial-Sloan Kettering Cancer Center

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

New York : Memorial Sloan Kettering Cancer Center

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

New York : Columbia Presbyterian Medical Center

Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL

New York : Weill Cornell Medical College

Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (THRiL) as Initial Treatment for Patients With CLL

New York : Memorial Sloan-Kettering Cancer Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

New York : Weill Medical College of Cornell

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

New York : Memorial Sloan-Kettering Cancer Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

New York : 1315.1.1002 Boehringer Ingelheim Investigational Site

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

New York : Weill Cornell Medical College

Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)

New York : Mount Sinai School of Medicine & Mount Sinai Graduate School of biological Sciences

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

New York : Weill Cornell Medical College

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

New York : Columbia University Medical Center

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

New York : Columbia Presbyterian - Harlem

KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

New York : Columbia University Medical Center

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

New York : Memorial Sloan-Kettering Cancer Center

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

New York : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

New York : Memorial Sloan-Kettering Cancer Center

Palifermin With or Without Leuprolide Acetate Versus Control for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

New York : New York Presby Hospital, Weill Medical College at Cornell University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Weill Cornell Medical College

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

New York : Memorial Sloan-Kettering Cancer Center

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

New York : Mount Sinai Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

New York : Weill Cornell Medical College

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

New York : Memorial Sloan Kettering Cancer Ctr

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

New York : Cornell University

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

New York : Memorial Sloan Kettering Cancer Center

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

New York : Memorial Sloan-Kettering Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Weill Cornell Medical College

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Memorial Sloan Kettering Cancer Center

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

New York : Weill Medical College of Cornell

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

New York : Advanced Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New York : St. Lukes Roosevelt Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New York : Memorial Sloan Kettering Cancer Center

Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies

New York : Children's Hospital New York-Presbyterian

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

New York City : Columbia Presbyterian Medical Center

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

New York City : New York Hospital Weill Cornell Medical Center

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Rochester : Univ. of Rochester Cancer Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Rochester : University of Rochester Medical Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Rochester : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Stony Brook : Stony Brook University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Stony Brook : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Stony Brook : Stony Brook University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Stony Brook : Stony Brook University Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Syracuse : SUNY Upstate Medical University

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Syracuse : SUNY Upstate Medical University - Adult Program

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Syracuse : Suny Upstate Medical University

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Syracuse : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Valhalla : Investigational Site Number 840009

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Valhalla :

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Valhalla : New York Medical College

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Valhalla : New York Medical College, Division of Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Valhalla : New York Medical College, Division of Oncology/Hematology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

North Carolina

Cary : US Oncology - Cancer Centers of North Carolina - Cary

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cary : Waverly Hematology Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Chapel Hill : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Chapel Hill : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Chapel Hill : University of North Carolina Hospitals

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

View More »

Charlotte : Levine Children's Hospital

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Charlotte :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Charlotte : Levine Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Charlotte : Mecklenburg Medical Group

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Charlotte : Levine Children's Hospital at Carolinas Medical Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Durham : Site Reference ID/Investigator# 71393

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Durham : Duke University Medical Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Durham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Participants With Acute Leukemia

Durham : Duke University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Durham : Research Site

AMG 319 Lymphoid Malignancy FIH

Durham : Duke University Medical Center

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Durham : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Durham : Duke University

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Durham : Duke University Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Durham : Duke University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Durham : Duke University Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gastonia : Gaston Hematology Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Greenville : East Carolina University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Bern : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Raleigh : Cancer Centers of North Carolina Cancer Centers of NC-Raleigh

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Raleigh : US Oncology - Cancer Centers of North Carolina - Macon

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Raleigh : US Oncology - Cancer Centers of North Carolina - Falls

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Raleigh : Rex Cancer Center

Telemonitoring Study - for Chronic Myeloid Leukemia (CML)

Raleigh : Rex Cancer Center - Wakefield

Telemonitoring Study - for Chronic Myeloid Leukemia (CML)

Winston-Salem : Wake Forest University

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Winston-Salem : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Winston-Salem : Wake Forest University Health Sciences

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

North Dakota

Bismarck :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Bismarck : Legacy Pharma Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bismarck : Mid Dakota Clinic/Odyssey Research

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fargo : Roger Maris Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Ohio

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia

View More »

Akron : Summa Health System - Cancer Research Office

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Akron : Summa Health System Hospitals

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Akron : Akron General Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Canton : Call for Information (Investigational Site 0035)

A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)

Canton : Investigational Site Number 840014

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Canton : Gabrail Cancer Center Research

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Canton : Gabrail Cancer Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Canton : Gabrail Cancer Center Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Canton : Nashat Y. Gabrail, MD, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Canton : Gabrail Cancer Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Cincinnati : Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Cincinnati : The Christ Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Cincinnati : Cincinnati Children'S Hospital Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Cleveland : Cleveland Clinic

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Cleveland : Cleveland Clinic Foundation

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Cleveland : Case Western Reserve University Hospitals of Cleveland

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Cleveland : University Hospitals Case Medical Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Cleveland : Cleveland Clinic

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Cleveland : Cleveland Clinic Taussig Cancer Center

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Cleveland : Cleveland Clinic

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Cleveland : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Cleveland : Case Western Reserve University, University Hospitals of Cleveland

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Cleveland Clinic, Taussig Cancer Institute

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Cleveland Clinic

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Cleveland : University Hospitals Case Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Cleveland : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Cleveland : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Cleveland : University Hospitals fo Cleveland

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Cleveland : University Hospitals Case Medical Center

Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

Columbus : The Ohio State University

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Columbus : The Ohio State University Comprehensive Cancer Center

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Columbus : James Cancer Hospital

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Columbus : The Ohio State University Medical Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Columbus : 1315.1.1001 Boehringer Ingelheim Investigational Site

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

Columbus : Ohio State University Medical Center

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Columbus : The Ohio State University Medical Center

Bortezomib and Midostaurin With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Columbus : Mid Ohio Oncology / Hematology, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbus :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Columbus : Nationwide Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Columbus : For additional information regarding sites for this trial call (919) 465-4648

Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia

Columbus : Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Columbus : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Columbus : Ohio State University

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Columbus : Ohio State University Medical Center

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Columbus : Nationwide Childrens Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Dayton : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Dayton : The Children'S Medical Center Of Dayton

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Elyria : Hematology Oncology Center, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Middletown : Signal Point Clinical Research Center, Site #139 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Middletown : Signal Point Clinical Research Center, LLC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Newark : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Newark : Medical Center of Newark

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Toledo : Mercy Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Oklahoma

Oklahoma City : University Of Oklahoma Health Sciences Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Oklahoma City : University of Oklahoma Health Science Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Oklahoma City : University of Oklahoma Health Sciences Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Tulsa : Cancer Care Associates

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Oregon

Eugene : Willamette Valley Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Eugene : Willamette Valley Cancer and Research / USOR

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : Oregon Health & Sciences University

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Portland : Oregon Health & Sci Univ

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

View More »

Portland : Northwest Cancer Specialists, PC

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Portland : Oregon Health and Science University

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

Portland : Oregon Health & Sciences

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Portland :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Portland : Northwest Cancer Specialists Salmon Creek Office

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Portland : Oregon Health Sciences University

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Portland : Oregon Health & Science University

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : Oregon Health & Science University Dept. Hematologic Malignancies

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Portland : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Portland : Legacy Emanuel Hospital & Health Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Portland : Oregon Health & Science University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Portland : Oregon Health & Science University

Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients

Salem : Hematology/Oncology Salem LLP

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Springfield : Willamette Valley Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Springfield : Willamette Valley Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Springfield : Willamette Valley Cancer Institute and Research Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Springfield : US Oncology Research: Willamette Valley Cancer Institute and Research Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Springfield : Willamette Valley Cancer Institute and Research Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Tualatin : Northwest Cancer Specialists, PC

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Tualatin : Northwest Cancer Specialists, PC

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Tualatin : Northwest Cancer Specialists, P.C.

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Pennsylvania

Bethlehem : Oncology Hematology of Lehigh Valley

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Danville : Geisinger Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Drexel Hill : Consultants in Medical Oncology and Hematology, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Gettysburg : Gettysburg Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Harrisburg : Andrews and Patel Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Hershey : Penn State Milton S. Hershey Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Hershey : Penn State Hershey Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Hershey : Penn State Hershey Cancer Institute

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Kingston : US Oncology - Medical Oncology Associates (Nahar)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kingston : Medical Oncology Associates of Wyoming Valley, PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lancaster : Lancaster Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lancaster : Lancaster General Health

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Norristown : Luitpold Pharmaceuticals, Inc.

Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

Philadelphia : Children's Hospital of Philadelphia Pediatric Oncology Clinic

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Philadelphia : University of Pennsylvania, Abramson Cancer Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Philadelphia : Children'S Hospital Of Philadelphia

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Philadelphia : Fox Chase Cancer Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Philadelphia : Investigational Site Number 840001

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Philadelphia : Abramson Cancer Center of the University of Pennsylvania

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Philadelphia :

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Philadelphia : Hospital of the University of Pennsylvania

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Philadelphia : Thomas Jefferson University

Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma

Philadelphia : Hospital of the University of Pennsylvania

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Philadelphia : Thomas Jefferson University

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Philadelphia : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Philadelphia : Children'S Hospital Of Philadelphia

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Philadelphia : University of Pennsylvania, Abramson Cancer Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Philadelphia : University of Pennsylvania Health System

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Philadelphia : Temple University at Jeanes Hospital

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Philadelphia : Hospital of the University of Pennsylvania

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Philadelphia : Abramson Cancer Center of the University at Perlman Center for Advanced Medicine

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Philadelphia : Thomas Jefferson University

Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias

Philadelphia : Abramson Cancer Center of the University of Pennsylvania

Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

Pittsburgh : Western Pennsylvania Hospital

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Pittsburgh : Children'S Hospital Of Pittsburgh

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Pittsburgh : (160) The Western Pennsylvania Hospital- Cancer Institute

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Pittsburgh : Children's Hospital of Pittsburgh

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Pittsburgh : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Pittsburgh : Children'S Hospital Of Pittsburgh Of Upmc

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Pittsburgh : The Western Pennsylvania Hospital

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Pittsburgh : Veterans Research Foundation of Pittsburgh

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Pottstown : Pottstown Memorial Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Reading : Berks Hematology Oncology Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Sayre : Call for Information (Investigational Site 0048)

A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)

West Reading : Berks Hematology-Oncology Associates

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wilkes Barre : Geisinger Health System

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Willow Grove : Abington Hematology Oncology Associates

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

York : Cancer Care Association Of York

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Rhode Island

Cranston : Hematology & Oncology Associates of Rhode Island

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cranston : Sambandam and Joseph Associates, Inc

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Cranston : Hematology and Oncology Associates of RI

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

South Carolina

Charleston : Charleston Hematology Oncology

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Charleston : Medical University of South Carolina, Hollings Cancer Center

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Charleston : Charleston Hematology Oncology Associates, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Charleston : Charleston Hematology Oncology, PA

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Charleston : Medical University of South Carolina

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

View More »

Charleston : Medical University of South Carolina MUSC/HCC (2)

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Charleston : Investigational Site Number 840002

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Charleston : Charleston Hematology and Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Charleston : Medical University of South Carolina

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Charleston : Charleston Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Charleston : Medical University of South Carolina

Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

Columbia : Liberty Hematology Oncology

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Columbia : South Carolina Oncololgy Associates, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbia : South Carolina Oncology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Easley : US Oncology - Cancer Centers of the Carolinas - Easley

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : Cancer Centers of the Carolinas

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Greenville : Cancer Centers of the Carolinas CCC Greenville

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Greenville : Cancer Centers of the Carolinas

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Greenville : Saint Francis Hospital

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : Bon Secours St. Francois Health System

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Greenville : Greenville Hospital System

Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

Hilton Head Island : South Carolina Cancer Specialists

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Sumter : Carolina Hematology Oncology, Site #143 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

South Dakota

Sioux Falls : (120) Avera Cancer Institute

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Sioux Falls : Sanford Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Watertown : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Watertown : Prairie Lakes Healthcare System, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Tennessee

Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Collierville : Family Cancer Center, PLLC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Collierville : The Family Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Germantown : The Jones Clinic

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Germantown : C. Michael Jones, MD, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Knoxville : East Tennessee Children'S Hosp

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Knoxville : Tennessee Cancer Specialists

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Memphis : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Memphis : St. Jude Children's Research Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Memphis : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Memphis : Family Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Memphis : St. Jude

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Nashville : Sarah Cannon Cancer Center

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Nashville : Vanderbilt-Ingram

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Nashville : Sarah Cannon Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Nashville : Sarah Cannon Research Institute

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Nashville :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Nashville : Vanderbilt University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Nashville : Sarah Cannon Research Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Nashville : Tennessee Oncology Dept. of Centennial Medical

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Nashville : SCRI

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Nashville : Vanderbilt U Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Nashville : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Nashville : Vanderbuilt University

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Nashville : SCRI

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Nashville : Tennessee Oncology, Pllc

Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib

Nashville : Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Nashville : Henry-Joyce Cancer Clinic

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nashville : Tennessee Oncology, PLLC

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nashville : Sarah Cannon Research Institute

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Nashville : Vanderbilt University

Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission

Nashville : Vanderbilt Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Texas

Abilene : US Oncology - Texas Cancer Center - Abilene (South)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Amarillo : US Oncology - Texas Oncology, PA - Amarillo

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Amarillo : Texas Oncology

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Amarillo : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Arlington : US Oncology - Texas Oncology - Arlington South

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Arlington : Texas Oncology - Arlington South

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Austin : Texas Oncology

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Austin : Dell Children'S Medical Center Of Central Texas

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Austin : US Oncology - Texas Oncology Austin, Site #172 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Austin : Texas Oncology-Austin North

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Beaumont : Julie & Ben Rogers Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Bedford : Texas Oncology, P.A.

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Bedford : US Oncology - Texas Oncology, PA - Bedford

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bryan : St. Joseph Regional Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

College Station : Scott & White Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : South Texas Institute of Cancer

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : Coastal Bend Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : Driscoll Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Dallas : Texas Oncology PA

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Dallas : (105) University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age

Dallas : Baylor Charles A. Sammons Cancer Center at Dallas

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Dallas : Mary Crowley Cancer Research Centers - Medical City

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Dallas : Baylor University Medical Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Dallas : UT Southwestern Medical Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Dallas : Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Dallas : Texas Oncology, P.A. Texas Oncology - Sugar Land

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Dallas : Texas Oncology - Dallas Presbyterian

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Dallas : Texas Oncology - Medical City Dallas

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Dallas : US Oncology - Texas Oncology, PA - Dallas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Dallas :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Dallas : Ut Southwestern

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Dallas : University of Texas Southwestern Medical Center

Phase II Study of Crenolanib in Subjects With Relapsed AML With FLT3-D835 Activating Mutations

Dallas : US Oncology - Texas Oncology Dallas, Site #171 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Dallas : University of Texas Southwestern Medical Center at Dallas

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Dallas : University of Texas Southwestern Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Dallas : UT Southwestern Medical Center at Dallas

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dallas : Texas Oncology-Methodist Charlton Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Dallas : Texas Oncology-Dallas Presbyterian Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Dallas : Texas Oncology-Medical City Dallas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

El Paso : US Oncology - El Paso Cancer Treatment Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

El Paso : US Oncology - El Paso Cancer Treatment Center - West

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : Texas Oncology, P.A.

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Fort Worth : Texas Oncology, P.A.

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Fort Worth : Texas Oncology, P.A.

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Fort Worth : Texas Oncology - Fort Worth 12th Avenue

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Fort Worth : Cook's Children's Medical Center

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : US Oncology - Southwest Fort Worth Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : JPS Center for Cancer Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fort Worth : Cook Children'S Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Grapevine : US Oncology - Texas Oncology - Grapevine

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : UT MD Anderson Cancer Center

2CDA With Rituximab in Hairy Cell Leukemia

Houston : UT MD Anderson Cancer Center

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Houston : Site Reference ID/Investigator# 48326

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Houston : MD Anderson Cancer Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Houston : MD Anderson Cancer Center

A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations

Houston : Md Anderson Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Houston : Texas Children'S Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Houston : M.D. Anderson Cancer Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Participants With Acute Leukemia

Houston : M.D. Anderson Cancer Center

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Houston : MD Anderson Cancer Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Houston : Texas Children's Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Houston :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Houston : Pfizer Investigational Site

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Houston : MD Anderson Cancer Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Houston : M.D. Anderson Cancer Center

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Houston : Site Reference ID/Investigator# 26522

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Houston : UT MD Anderson Cancer Center

Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin

Houston : MD Anderson Cancer Center

A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases

Houston : MD Anderson Cancer Center

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center/University of Texas

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Houston : Baylor College of Medicine Baylor College of Medicine (3)

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Houston : MD Anderson Cancer Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Houston : MD Anderson Cancer and Research Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Houston :

An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies

Houston : MD Anderson

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Houston : UT MD Anderson Cancer Center

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

Houston : MD Anderson Cancer Center / University of Texas

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Houston : M D Anderson Cancer Center

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Houston : University of Texas MD Anderson Cancer Center

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Houston : UT MD Anderson Cancer Center

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

Houston : UT MD Anderson Cancer Center

Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)

Houston : Oncology Consultants

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : MD Anderson Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : The University Of Texas - M.D. Anderson Cancer Center

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Houston : The University of Texas MD Anderson Cancer Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Houston : UT MD Anderson Cancer Center

Eltrombopag for Management of Thrombocytopenia

Houston : University of Texas MD Anderson Cancer Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Houston : UT MD Anderson Cancer Center

Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies

Houston : UT MD Anderson Cancer Center

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

Houston : UT MD Anderson Cancer Center

Hyper CVAD Plus Ofatumumab in CD - 20 Positive Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients

Houston : M. D. Anderson Cancer Center at University of Texas

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Houston : MD Anderson Cancer Center/University of Texas UT MD Anderson

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Houston : UT MD Anderson Cancer Center

Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)

Houston : U.T. M.D. Anderson Cancer Center

Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy

Houston : UT MD Anderson Cancer Center

Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Houston : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Houston : Baylor College Of Med/Tx Chldrns Cancer & Hem Ctrs.

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Houston : UT MD Anderson Cancer Center

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Houston : The University of Texas MD Anderson Cancer Center

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Houston : UT MD Anderson Cancer Center

Phase I/II - Dasatinib and Decitabine

Houston : MD Anderson Cancer Center

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Houston : UT MD Anderson Cancer Center

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Houston : UT MD Anderson Cancer Center

Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Houston : The University of Texas M.D. Anderson Cancer Center

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)

Houston : UT MD Anderson Cancer Center

Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL

Houston : UT MD Anderson Cancer Center

PKC412 and 5-Azacytidine

Houston : UT MD Anderson Cancer Center

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

Houston : UT MD Anderson Cancer Center

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

Houston : University of Texas M. D. Anderson Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Houston : UT MD Anderson Cancer Center

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Houston : University of Texas M.D. Anderson Cancer Center

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Houston : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Houston : UT MD Anderson Cancer Center

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Houston : UT MD Anderson Cancer Center

Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)

Houston : Investigational Site Number 840001

SAR3419 in Acute Lymphoblastic Leukemia

Houston : MD Anderson Cancer Center

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome

Houston : Investigational Site Number 840003

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Houston : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Houston : UT MD Anderson Cancer Center

Study of Dasatinib in Patients With Chronic Myelogenous Leukemia

Houston : University of Texas M.D. Anderson Cancer Center

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Houston : MD Anderson Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Houston : MD Anderson Cancer Center

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Houston : Call for Information (Investigational Site 0002)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Houston : The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

Houston : The University Of Texas Md Anderson Cancer Center

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Houston : MD Anderson Cancer

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Houston : Michael DeBakey VA Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Houston : MD Anderson Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Houston : University of Texas - MD Anderson Cancer Center

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Houston : MD Anderson Cancer Center

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Houston : UT MD Anderson Cancer

Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Houston, : M.D. Anderson Cancer Center

Clinical Study of PM01183 in Patients With Acute Leukemia

Houston, Texas : The University of Texas, M.D. Anderson Cancer Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lackland AFB : Wilford Hall Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Laredo : South Texas Research Alliance, LLC

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Lewisville : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Longview : US Oncology - Longview Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lubbock : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Lubbock : Joe Arrington Cancer Research and Treatment Center

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Lubbock : Joe Arrington Cancer Research and Treatment Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

McAllen : US Oncology - Texas Oncology - McAllen

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

McAllen : Texas Oncology-McAllen South Second

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Mesquite : US Oncology - Texas Oncology - Mesquite

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Mesquite : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Midland : US Oncology - Allison Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Midland : US Oncology - Texas Oncology Midland, Site #173 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Midland : Texas Oncology-Midland Allison Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Odessa : Texas Oncology-Odessa West Texas Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Paris : US Oncology - Texas Oncology - Paris

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Paris : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Plano : North Texas Regional Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Round Rock : Texas Oncology - Central Austin Cancer Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

San Antonio : Cancer Care Network of South Texas

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

San Antonio : Cancer Care Centers of South Texas

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

San Antonio : Cancer Care Network of South Texas

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

San Antonio :

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

San Antonio : Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2)

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

San Antonio : US Oncology - Cancer Care Centers of South Texas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

San Antonio : University of Texas Health Science Center, San Antonio

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

San Antonio : US Oncology - Cancer Care Center of South Texas, Site #170 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

San Antonio : Cancer Care Centers of South Texas

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

San Antonio : Cancer Therapy Reasearch Center at UTHSCA

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

San Antonio : Texas Transplant Physician's Group

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

San Antonio : Cancer Care Centers of South Texas

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Antonio : Cancer Care Centers of South Texas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Sherman : US Oncology - Texas Oncology - Sherman

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Temple : Scott and White Hospital and Clinic

A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases

Temple : Scott & White Healthcare Department of Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Temple : Scott & White Healthcare

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Temple : Central Texas Veterans Health Care System

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Tyler : ETMC dba Blood and Cancer Center - East Texas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Tyler : US Oncology - Texas Oncology - Tyler

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Tyler : ETMC dba Tyler Hematology Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waco : US Oncology - Texas Oncology Cancer Care and Research Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waco : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Weslaco : US Oncology - Texas Oncology - Weslaco

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wichita Falls : US Oncology - Texoma Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Utah

American Fork : Central Utah Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Ogden : Northern Utah Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Salt Lake City : University of Utah

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

Salt Lake City : Huntsman Cancer Institute at the University of Utah

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

View More »

Salt Lake City : University of Utah, Huntsman Cancer Institute

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

Salt Lake City :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Salt Lake City : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Salt Lake City : Huntsman Cancer Institute, Site #043 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Virginia

Abingdon : Cancer Outreach Associates, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Arlington : US Oncology - Arlington Fairfax Hematology Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Charlottesville : Virginia University

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Charlottesville : University of Virginia Health System

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Christianburg : Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

View More »

Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fairfax : Virginia Cancer Specialists, PC

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Fairfax : Virginia Cancer Specialists, PC

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Fairfax : Virginia Cancer Specialists, PC

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Falls Church : Inova Fairfax Medical Center

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Fredericksburg : Hematology Oncology Associates of Fredricksburg

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Newport News : Peninsula Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Norfolk : Children'S Hosp-Kings Daughter

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Richlands : Virginia Oncology Care, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Richmond : Massey Cancer Center/Virginia Commonwealth University

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc.

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Roanoke : Blue Ridge Cancer Care

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Winchester : US Oncology - Shenandoah Oncology - Winchester

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Washington

Bellingham : Peace Health Medical Group

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Edmonds : Puget Sound Cancer Centers

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Everett : Providence Everett Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kennewick : Columbia Basin Hematology and Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Seattle : Site Reference ID/Investigator# 52882

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Seattle : Fred Hutchinson Cancer Research Center

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Seattle : Seattle Cancer Care Alliance

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Seattle : Seattle Children'S

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Seattle : Seattle Cancer Care Alliance

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Seattle : Fred Hutchinson Cancer Research Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Seattle :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Seattle : Seattle Children's Hospital CPKC412A2114

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Seattle : US Oncology - Puget Sound Cancer Center - Seattle

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Seattle :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Seattle : Seattle Children's Hospital

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Seattle : University Of Washington

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Seattle : University of Washington

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Seattle : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Seattle : Fred Hutchinson Cancer Research Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Seattle : Fred Hutchinson Cancer Research Center

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Seattle : Fred Hutchinson Cancer Research Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Seattle : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Seattle : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Seattle : Seattle Cancer Care Alliance

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Seattle : Swedish Tumor Institute-Medical Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Seattle : Fred Hutchinson Cancer Research Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Seattle : Seattle Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Spokane : Cancer Care Northwest, US Oncology

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Spokane : US Oncology - Cancer Care Northwest - Holland

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : US Oncology - Cancer Care Northwest - Sherman

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : Medical Oncology Associates PS

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : US Oncology - Cancer Care Northwest - Mission

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : Providence Cancer Center at Sacred Heart Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Spokane Valley : Cancer Care Northwest

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Tacoma : Northwest Medical Specialties

A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Vancouver : US Oncology - Northwest Cancer Specialists, Site #174 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Walla Walla : Providence St. Mary Regional Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Walla Walla : Providence St. Mary Regional Cancer Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wenatchee : Wenatchee Valley Medical Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Wenatchee : Wenatchee Valley Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Yakima : Yakima Valley Memorial Hospital/North Star Lodge

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Yakima : Yakima Valley Memorial Hospital

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Yakima : Yakima Valley Memorial Hospital / North Star Lodge

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Yakima : Yakima Regional Cancer Care

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Yakima : Yakima Valley Memorial Hospital / North Star Lodge

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Yakima : North Star Lodge Cancer Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Yakima : Yakima Valley Memorial Hospital/North Star Lodge

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)

Morgantown : West Virginia University - Clinical Trials Research Unit

ECOG 10404: Randomizewd Ph2, Three Fludarabine/Antibody Combinations for patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

S0535 - A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated, High-Risk Acute Promyelocytic Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

S0805 - Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without allogeneic stem cell transplant in Patients with Philadelphia(Ph)Chromosome Postive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia(ALL)

View More »

Martinsburg : City Hospital - West Virginia University Hospital East

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Morgantown : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Morgantown : Investigational Site Number 840002

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Morgantown : West Virginia University Hospital

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Morgantown : Department of Medicine Section of Hematology/Oncology, West Virginia University Hospitals, Mary Babb Randolph Cancer Center, West Virginia University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Wheeling : Wheeling Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Wisconsin

Green Bay : St. Vincent Hospital/Green Bay Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Green Bay : St Vincent Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Green Bay : St Vincent Regional Cancer Center

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Green Bay : Bellin Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Janesville : Mercy Health System Heme/Onc

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

View More »

LaCrosse : Gundersen Clinic

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Madison : Site Reference ID/Investigator# 56811

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Madison :

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Madison : University of Wisconsin

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Madison : Kenneth DeSantes., MD

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Madison : University of Wisconsin Carbone Cancer Center

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Madison : University of Wisconsin

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Marshfield : Marshfield Clinic

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Milwaukee : Children's Hospital of Wisconsin

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Milwaukee : The Medical College of Wisconsin

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Milwaukee : Medical College of Wisconsin

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Milwaukee : Medical College Of Wisconsin

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Milwaukee : Medical College of Wisconsin

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Milwaukee : Medical College of Wisconsin

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Oconomowoc : Oconomowoc Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Waukesha : Waukesha Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waukesha : Waukesha Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Wausau : Aspirus Regional Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Wisconsin Rapids : Riverview Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Argentina

Buenos Aires :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Buenos Aires : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Buenos Aires : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Buenos Aires : Novartis Investigative Site

Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

Buenos Aires : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

View More »

Buenos aires : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Bunos Aires : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Capital Federal : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Cordoba : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Córdoba :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Derqui, Pilar : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

El Palomar : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Rio Negro : Novartis Investigative Site

Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

Rio Negro : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Australia

Adelaide : IMVS

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Adelaide : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Adelaide : Royal Adelaide Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Adelaide : IMVS

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Adelaide : Flinders Medical Centre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

View More »

Adelaide : Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bedford Park : Flinders Medical Centre

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brisbane :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Camperdown : Royal Prince Alfred Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Clayton : Investigational Site Number 036002

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Clayton : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Concord : Concord Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Concord : Concord Repatriation General Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Darlinghurst : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

East Melbourne : Site Reference ID/Investigator# 48323

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

East Melbourne : Site Reference ID/Investigator# 70394

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

East Melbourne : Peter MacCallum Cancer Centre

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia

East Melbourne : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Fitzroy : St. Vincent's Hospital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Fitzroy :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Fitzroy : St. Vincent's Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Fitzroy : St. Vincent Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Footscray : The Western Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Frankston : Frankston Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Garran : The Canberra Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Geelong : Andrew Love Cancer Center, Geelong Hospital, Barwon Health

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Gosford : Haematology Department, Gosford Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Herston : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Herston : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Herston : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Herston, Brisbane : Royal Brisbane and Women's Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hobart : Investigational Site Number 036001

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Kingswood : Nepean Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Kingswood : Nepean Cancer Care Centre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Kogarah :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Kogarah : The St. George Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Kurralta Park :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Malvern : Cabrini Hospital

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia

Melbourne :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Melbourne : Royal Melbourne Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Melbourne : The Alfred Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nedlands : Sir Charles Gairdner Hospital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Nedlands : Sir Charles Gairdner Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Nedlands : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

New Lambton Heights :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Newcastle : Calvary Mater Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

North Adelaide : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Northmead : Westmead Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Parkville : Site Reference ID/Investigator# 48322

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Parkville : Site Reference ID/Investigator# 70393

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed or Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Parkville : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Parkville : Royal Melbourne Hospital

A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission

Parkville :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Parkville : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Parkville : Department of Clinical Haematology and BMT Service, Royal Melbourne Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Perth : Investigational Site Number 036003

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Perth : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Perth : Royal Perth Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Prahran : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Prahran : The Alfred Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Randwick : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Randwick : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

St. Leonards : Royal North Shore Hospital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

St. Leonards : Royal North Shore Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

St. Leonards : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Sydney : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Westmead :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Westmead : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Westmead : Westmead Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Westmead, NSW : Children's Hospital at Westmead

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Woolloongabba : Princess Alexandra Hospital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Woolloongabba : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Woolloongabba : Princess Alexandra Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Austria

Feldkirch : LKH Feldkirch, Interne E

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Feldkirch : LKH Feldkirch, Interne E

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Graz : 1102 - LKH Graz

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Graz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Graz : Universitatsklinik Graz, Universitatsklinik fur Innere Medizin, Abteilung fur Hamatologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

View More »

Hall : A.ö. Bezirkskrankenhaus Hall in Tirol, Innere Medizin / Hämato - Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Innsbruck : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie

Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL

Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Innsbruck : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Innsbruck : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Innsbruck : Medizinische Universität Innsbruck

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Innsbruck : Universitätsklinik Innsbruck, Innere MEdizin IV / Hämato-Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Innsbruck : Innsbruck Medical University

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Innsbruck : University Hospital for Internal Medicine V, Innsbruck Medical University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Krems : Landesklinikum Krems, Hämato-onkologisches Service

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Kufstein : A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Linz : Krankenhaus der Barmherzigen

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Linz : 1107 - Krankenhaus der Elisabethinen

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Linz : Krankenhaus der Elisabethinen Linz GmbH, 1. Interne

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : Krankenhaus d. Barmherzigen Schwestern Linz, Interne I

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Linz : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Linz : Krankenhaus der Barmherzigen Schwestern Linz

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Linz : Krankenhaus der Elisabethinen Linz GmbH

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Linz : AKH Linz, Department für Innere Medizin 3

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Salzburg : Center for Clinical Cancer and Immunology Trials

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Salzburg : 1106

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III

Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL

Salzburg : Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Salzburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Salzburg : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Salzburg : Universitätsklinik für Innere Medizin III Salzburg

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Salzburg : Landeskrankenhaus Salzburg, Universitaetsklinik fur innere Medizin lll, Universitaetsklinikum der PMU

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Steyr : Landeskrankenhaus Steyr, Innere Medizin, Hämatologie, Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Vienna : Medical University of Viena

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Vienna : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Vienna : St. Anna Kinderspital

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Vienna : 1101 - AKH Wien

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Vienna : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Vienna : Medical University of Vienna

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wels : Abteilung für Innere Medizin IV

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Wels : Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Wels : Klinikum Wels-Grieskirchen GmbH, Abteilung für Innere Medizin IV

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wien : Wilhelminenspital

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Wien : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Wien : Hanusch Krankenhaus, 3. Med. Abtlg. Für Hämatologie und Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Wien : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wien : Hanuschkrankenhaus Wien

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Wien : Hanusch Krankenhaus, 3. Med. Abtlg.

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wien : AKH Wien, Klinische Abteilung für Hämatologie und Hämostaseologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wien : AKH Wien / MedUniWien Universtatsklinik fur Innere Medizin 1

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Belgium

Antwerp : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Antwerp : Ziekenhuis Netwerk Antwerpen

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Antwerpen : Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Antwerpen : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Antwerpen : 1504

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

View More »

Antwerpen : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Antwerpen : ZNA Middleheim Lindendreef 1

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Antwerpen : ZNA Stuivenberg, Lange Beeldekensstraat 267

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brasschaat : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Brugge : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Brugge : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Brugge : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brugge : AZ St.-Jan Brugge-Oostende AV

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brügge : 1505

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Brussels : 1502 - Cliniques Universitaires de Saint-Luc

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Brussels : Institute Jules Bordet, Department of Hematology

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Brussels : Cliniques universitaires Saint-Luc

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Brussels : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brussels : Institut Jules Bordet

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brussels : CHU Erasme Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brussels : Cliniques Universitaires Saint Luc

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bruxelles : Investigational Site Number 056003

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Bruxelles : Hopital Des Enfants Reine Fabiola

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bruxelles : Hopital Saint Luc

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bruxelles : 1270.1.32001 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Bruxelles : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Gent : Investigational Site Number 056002

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Gent : UZ Gent

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Gent : 1270.1.32003 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Gent : 1503

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Gent : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Gent : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Gent : Universitair Ziekenhuis Gent

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Godinne : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Haine Saint Paul : Hopital de Jolimont

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Haine-Saint Paul : Hopital de Jolimont

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Haine-saint-Paul : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hasselt : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Kortrijk : AZ Groeninge

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Kortrijk : AZ Groeninge Kortrijk

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Leuven : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Leuven : Investigational Site Number 056001

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Leuven : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Leuven : 1270.1.32002 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Leuven : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Leuven : University Hospital Gasthuisberg, Department of Hematology

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Leuven : UZ Gasthuisberg - Department of Hematology, Site #700 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Leuven : UZ Leuven

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Leuven : UZ Leuven, campus Gasthuisberg, Department of Haematology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Liege : Chr de La Citadelle

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Liege : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Montegnee : Chc Esperance

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Montigny-Le Tilleul : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Roeselare : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Roeselare : H. Hartziekenhuis Roeselare-Menen vzw

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Roeselare : H.-Hartziekenhuis Roeselare - Menen vzw

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Turnhout : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Wilrijk : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Yvoir : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Yvoir : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Yvoir : 1501 - Cliniques Universitaires UCL de Mont Godinne

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Yvoir : CHU de Mont-Godinne

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Yvoir : Clinique Universitaire de Mont Godinne

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brazil

Barretos : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Barretos : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Barretos : Fundacao Pio XII - Hospital de Cancer de Barretos

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Belo Horizonte : BIOCANCER - Centro de Pesquisa e Tratamento do Câncer S/A

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brasílía : Hospital Universitario de Brasilia

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

View More »

Curitiba : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Curitiba : Hospital Erasto Gaertner

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Goiania :

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Goiania : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Jaú : Novartis Investigative Site

Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

Londrina : Pro Onco Centro de Tratamento Oncológico

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Morumbi : Hospital Israelita Albert Einstein

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Porto Alegre : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Porto Alegre :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Porto Alegre : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Porto Alegre : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Porto Alegre : Hospital Nossa Senhora da Conceição

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Porto Alegre : Hospital de Clínicas de Porto Alegre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Rio de Janeiro : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Rio de Janeiro : Instituto Estadual Arthur de Siqueira Cavalcanti - HEMORIO

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Rio de Janeiro : Instituto Nacional Del Cancer

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Salvador : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Salvador : Monte Tabor Hospital Sao Rafael

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Santo Andre : Centro de Estudos e Pesquisas de Hematologia e Oncologia da

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Sao Paulo : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Sao Paulo : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Sao Paulo :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Sao Paulo : Instituto de Ensino e Pesquisa São Lucas

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Sao Paulo : Fundacao Antonio Prudente - Hospital do Cancer AC Camargo

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

São Paulo : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

São Paulo : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Bulgaria

Pleven : Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Plovdiv : Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Sofia : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Sofia : Military Medical Academy Clinic of Hematology and Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Varna : UMHAT Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Canada

Calgary :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Calgary : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Calgary : Alberta Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Edmonton : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Edmonton : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

View More »

Edmonton :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Greenfield Park : Hopital Charles LeMoyne

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Greenfield Park : Charles LeMoyne Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Halifax : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Halifax :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Halifax : CDHA Centre for Clinical Research

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Halifax : Queen Elizabeth II Health Sciences Centre

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hamilton :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Hamilton : McMasters University Medical Center

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Hamilton : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Kirkland : Merck Frosst Canada Ltd.

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Kitchener : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

London : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Montreal : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Montreal :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Montreal : Royal Victoria Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Montreal : Hopital Maisonneuve Rosemont

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Montreal : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Montreal : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Montreal : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Montreal : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Montreal : Jewish General Hospital, Site #129 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Montreal : Hopital du Sacre-Coeur de Montreal

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ottawa : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Quebec : Hopital de L'Enfant-Jesus

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Québec : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Rimouski :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Saint John : Atlantic Health Sciences Corporation Saint John Regional Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Saint John : Saint John Regional Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Sainte-Foy : Quebec Children's Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Sherbrooke : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

St. Catherine : Hospital St. Justine

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

St. John : Atlantic Health Sciences Corporation, Saint John Regional Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

St. Johns : Health Sciences Center

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

St. Johns : Health Sciences Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Toronto :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Toronto : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Toronto : Univ. Health Network-Princess Margaret Hospital

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia

Toronto : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Toronto : Sick Children's Hospital

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Toronto :

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Toronto : Princess Margaret Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Toronto : University Health Network-Princess Margaret Hospital

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Toronto : Princess Margaret Hospital

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Toronto : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Toronto : University Health Network, Princess Margaret Hospital

Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

Toronto : Hospital for Sick Children

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Toronto : Novartis Investigative Site

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Toronto : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Toronto : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Toronto : University Health Network - Princess Margaret Hospital

Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia

Toronto : University Health Network, Princess Margaret Hospital, Site #083 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Toronto : Princess Margaret Hospital

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Toronto : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Toronto : Princess Margaret Hospital

SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Toronto : Princess Margaret Hospital

Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Toronto : University Health Network, Princess Margaret Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Toronto : Hospital for Sick Kids

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Vancouver : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Vancouver : Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit

A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib

Vancouver :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Vancouver : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Vancouver : Division of Hematology, Vancouver General Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Winnipeg : CancerCare Manitoba

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia

Chile

Renaca : Instituto Oncologico Anabaena 336 Vina del Mar V Region

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Santiago :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Temuco : Instituto Clinico Oncologico del Sur (ICOS) Lago Puyehue 01745 Temuco IX Region de La Araucania

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

China

Beijing :

A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma

Beijing : Beijing Clinical Service Center

Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia

Guangzhou :

A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma

Hong Kong : Department of Paediatrics and Adolescent Medicine, The University of Hong Kong

A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma

Shanghai :

A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma

View More »

Tianjin :

A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma

Tianjin : Hematologic hospital of Chinese academy of medical sciences

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Colombia

Monteria : Novartis Investigative Site

Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

Monteria : Oncomedica S.A

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Croatia

Zagreb :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Zagreb : University Hospital Dubrava

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Czech Republic

Bmo : Pfizer Investigational Site

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Brno : Lekarna fakultni nemocnice V Brne

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Brno : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brno : FN Brno

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Brno : University Hospital Brno

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

View More »

Brno : Fakultni nemocnice Brno, Interni hematoonkologicka klinika

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brno - Bohunice : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hradec Kralove : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hradec Kralove : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Hradec Kralove : FN Hradec Kralove

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Hradec Kralove : Faculty Hospital Hradec Kralove

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Hradec Kralove : Fakultni nemocnice Hradec Kralove, 2. Interni klinika-oddeleni klinicke hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Novy Jicin : Oncology Centre J.G. Mendela

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Olomouc : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Olomouc : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Olomouc : FN Olomouc

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Ostrava : Fakultni nemocnice Ostrava

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Plzen : Faculty Hospital Plzen

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Prague : General Faculty Hospital 1 - Internal Clinic

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Praha : VFN Praha 2

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Praha : FN Kralovske Vinohrady

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Praha : Ustavni lekarna Fakultni nemocnice Kralovske Vinoh

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Praha : Fakultni nemocnice Kralovske Vinohrady, Oddeleni klinicke hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Praha 2 : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Praha 2 : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Praha 2 : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Denmark

Aalborg : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Copenhagen : Rigshospitalet University Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Copenhagen : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Copenhagen : Copenhagen University Hospital Rigshospital

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Copenhagen : Rigshospitalet University Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

View More »

Herlev : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Herlev : Herlev Hospital

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Herlev : Copenhagen University Hospital at Herlev

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Koebenhavn Oe : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Roskilde : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Vejle : Vejle Hospital

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Egypt

Cairo : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Finland

Pori :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Tampere : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Vantaa :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

France

Aix En Provence :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Albi :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Amiens : Groupe Hospitalier Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Amiens : Hopital Nord

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Amiens : CHU Amiens

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

View More »

Amiens : CHU d'Amiens

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Amiens : Service d'hématologie pédiatrique CHRU

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Angers : Chu D'Angers

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Angers :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Angers : 1211 - CHU d'Angers

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Angers : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Angers : CHRU Angers

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Angers : CHU Angers

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Angers : Mathilde HUNAULT BERGER

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Angers : CHU Angers Service de Medecine D - Maladies du Sang

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Angers Cedex 01 : CHU Angers, Service des maladies du sang

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Angers cedex 09 : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Antibes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Argenteuil : CH Victor Dupouy

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Argenteuil :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Argenteuil : Hopital Victor Dupouy

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Argenteuil :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Arras :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Avignon :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Avignon :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Avignon : CHU Avignon Centre Hospitalier Henri Dufaut

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bayonne : Ch de La Cote Basque

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bayonne :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Bayonne : Centre hospitalier de la côte Basque

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Besancon : Hopital Saint Jacques

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Besancon : Hopital Jean Minjoz

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Besancon : CHU Hôpital Minjoz

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Besancon : Service hématologie pédiatrique Hôpital Saint-Jacques

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Besançon : 1210 - CHU de Besançon

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Beziers :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Blois :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Blois :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Blois cedex : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Bobigny : Hopital Avicenne

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Bobigny : Hopital Avicenne

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Bobigny :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Bobigny : Hôpital Avicenne Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bobigny : Hopital Avicenne- Departement Onco-hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bobigny Cedex : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Bobigny Cedex : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Bordeaux : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Bordeaux : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Bordeaux : Service d'Hematologie - Institut Bergonié

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Bordeaux :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Bordeaux : Hopital Pellegrin Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bordeaux :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Bordeaux : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Bordeaux : Novartis Investigative Site

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Bordeaux : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Bordeaux : Service d'hémato-oncologie - Hôpital des Enfants Pellegrin

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Bordeaux cedex : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Boulogne :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Bourg En Bresse :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Brest :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Brest :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Brest : CHU Morvan

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Brest : Hôpital Morvan

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Caen :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Caen : Chu Cote de Nacre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Caen :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Caen : CHU Caen Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Caen : Hématologie oncologie pédiatrique-CHU Caen

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Caen cedex 5 : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Carcassonne :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Castelnau Lez :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Cedex : CHU Côte de Nacre

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Cergy Pontoise : 1206 - Hôpital de Pontoise

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Cergy Pontoise : CH René Dubos

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Chalon Sur Saone :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Chambery :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clamart : Hôpital Militaire Percy

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Clermont : Service d'Hematolgie Clinique - CHU Estaing

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Clermont Ferrand : Chu Estaing

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Clermont Ferrand Cedex 1 :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clermont-ferrand :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clermont-Ferrand : CHU Hôtel Dieu

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Clermont-Ferrand : CHU Estaing

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Clermont-Ferrand : CHU Estaing Service d'hématologie

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Clermont-Ferrand : CHU de Clermont-Ferrand

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Clermont-Ferrand : Hémato-Oncologie et Thérapie Cellulaire Pédiatrique - Hôtel Dieu

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Clermont-Ferrand Cedex 1 : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Colmar :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Colmar : CH Louis Pasteur

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Corbeil Essonnes : Centre hospitalier sud francilien

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Corbeil-essonnes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret

A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974 AM1)

Creil :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Creteil :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Creteil : Hopital Henri Mondor

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Creteil : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Créteil : 1205 - CHU Henri Mondor

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Créteil : Hôpital Henri Mondor

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Dijon :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Dijon : Hopital Du Bocage

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Dijon : CHU du Bocage

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Dijon : Dijon hôpital d'enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Dijon : Hémato-Oncologie Pédiatrique - Hôpital d'Enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Frejus :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Grenoble : Chu Grenoble

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Grenoble :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Grenoble : CHU Michallon

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Grenoble : CHU de Grenoble

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Grenoble : Hôpital Michallon

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Grenoble : Pédiatrie CHU - Hôpital Nord

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Grenoble : Hopital A Michalon

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Grenoble cedex 9 : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

La Roche Sur Yon :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

La Tronche :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

La Tronche :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Le Chesnay : Ch de Versailles - Hopital Mignot

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Le Chesnay : Hopital Mignot

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Le Mans :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Le Mans :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Lens :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Libourne :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Lille :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Lille : Chru Lille

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lille : Chru Lille - Hop Jeanne de Flandres

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lille : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Lille : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Lille : CHRU - Hopital Claude HURIEZ

Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL

Lille : CHU Lille Hôpital Claude Huriez

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Lille : Hôpital Jeanne de Flandre

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Lille : CHU Lille, Service des maladies du sang, Hopital Huriez

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Lille cedex : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Lille Cedex : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Lille cedex : GSK Investigational Site

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Limoges :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Limoges : Chu Dupuytren

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Limoges : CHU Dupuytren

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Limoges : CHU Limoges Hopital Dupuytren

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Limoges : Limoges University Hospital

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Lyon :

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Lyon : Institut Hematologie Oncologie Pediatrique

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lyon :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Lyon : 1209 - CHU de Lyon

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Lyon : Centre hospitalier Lyon Sud

Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL

Lyon : Hôpital Edouard Herriot

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Lyon : Hôpital DEBROUSSE Institut d'hématologie et d'oncologie pédiatrique

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Lyon : Xavier THOMAS

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Lyon cedex 04 : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Lyon Cedex 08 : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Macon :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Marseille :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Marseille :

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Marseille : Chu Timone Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Marseille : Institut Paoli Calmettes

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Marseille :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Marseille : Institut Paoli Calmette

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Marseille : Novartis Investigative Site

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Marseille : Institute Paoli Calmettes

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Marseille : Institut Paoli Calmettes

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Marseille Cedex 09 : 1270.1.33002 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Marseille Cedex 09 : Institut Paoli - Calmettes

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Marseille Cedex 09 : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Marseille cedex 9 : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Marseille Cedex 9 : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Marseille Cedex 9 : Local Institution

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Maseille : Service hématologie pédiatrique CHU la Timone

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Meaux : Centre Hospitalier de Meaux

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Meaux : CH de Meaux

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Metz :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Metz : CH Metz Thionvile

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Metz Tessy :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montauban :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montpellier :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Montpellier :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Montpellier : Investigational Site Number 250002

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Montpellier : Hopital Saint Eloi

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Montpellier :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montpellier : CHU Lapeyronie

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Montpellier : Guillaume CARTRON

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Montpellier : CHU St Eloi

Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL

Montpellier : Hôpital Arnaud de Villeneuve

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Montpellier Cedex 5 : 1270.1.33001 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Montpellier Cedex 5 : CHU Saint Eloi

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Mulhouse :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Mulhouse : Hopital Emile Muller

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Mulhouse :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Mulhouse : CH Muller

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Mulhouse : Centre Hospitalier de Mulhouse

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Mulhouse : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Nancy : CHU Brabois

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Nantes :

A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Nantes : Hopital Mere Enfant

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nantes : Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nantes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Nantes : Hôpital de l'hôtel Dieu

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Nantes : 1212 - Hôpital de l'hôtel Dieu

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Nantes : CHU Hôtel Dieu

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Nantes : CHU de Nantes

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Nantes : CHR Hôtel Dieu

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Nantes : CHU Nantes Hotel Dieu, Service d'hematologie clinique

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nantes : Hospital Hotel Dieu, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Nantes Cedex : CHU Hotel Dieu

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Nantes Cedex 01 : Investigational Site Number 250006

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Nantes cedex 1 : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Nice :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Nice : Hopital de l'Archet 1

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Nice : Hopital de L'Archet 2

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nice :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Nice : 1213 - Centre Hospitalier Universitaire de Nice

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Nice : Centre Antoine Lacassagne

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Nice : Hôpital de L'archet I

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Nice : Hôpital de l'Archet

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Nice : Hopital de l'Archet

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Nimes :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Nimes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Nimes : CHU Carémeau

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Nimes Cedex : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Orleans :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Orléans : CH La Source

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Paris : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Paris :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Paris : Hopital Saint Louis

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Paris : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Paris :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Paris : Hopital Armand Trousseau

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Robert Debre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Necker Enfants Malades

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Saint Louis

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Saint Antoine

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Paris : 1201 - Hôpital Saint Louis

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Paris : Hopital Cochin (AP-HP)

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Paris : Hôpital Saint-Louis

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Paris : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Paris : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Paris : Hôpital Saint-Antoine

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Paris : Hôtel Dieu Sce Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Paris : Service hématologie Hopital Necker

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Paris : Hématologie Pédiatrique - Hôpital Trousseau

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Paris : Hémato-immunologie-Robert Debré

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Paris : Children Armand Trousseau Hospital

Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2

Paris : Hospital Saint Louis, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Paris Cedex 10 : Local Institution

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Paris cedex 12 : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Paris Cedex 15 : Hôpital Necker

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Paris Cedex 19 : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Perpignan :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Perpignan : Ch de Perpignan

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Perpignan :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Perpignan : CH Saint-Jean

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Perpignan : CHU Perpignan Centre Hospitalier Hôpital Saint-Jean

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Pessac : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Pessac : Hopital Haut-Leveque

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pessac : 1202 - CHU de Bordeaux - Hôpital Haut Lévêque

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Pessac : CHU du Haut Lévèque

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Pessac : CHU de Bordeaux - Hôpital Haut-Lévêque

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Pessac : CHU de Bordeaux- Hopital Haut-Leveque, Centre Francois Magendle

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Pessac cedex : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Pessac cedex : GSK Investigational Site

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pierre Benite :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Pierre Benite :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Pierre Benite : Hopital Lyon Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pierre Benite :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Pierre Benite :

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Pierre Benite : Centre Hospitalier Lyon Sud - Service d'Hematologie - Pavillon Marcel Berard - Bat. 1G - 1er etage, 165 Chemin du grand Revoyet

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Pierre Benite : Local Institution

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Pierre Bénite : Centre hospitalier Lyon Sud

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Pierre Benite Cedex : Investigational Site Number 250001

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Pierre Benite Cedex : CHU Lyon Sud

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Pierre-Bénite cedex : GSK Investigational Site

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Poitiers : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Poitiers : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Poitiers : CHU La Miletrie

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Poitiers :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Poitiers : CHU Jean Bernard - La Milétrie

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Poitiers : CHU de Poitiers

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Poitiers : Novartis Investigative Site

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Poitiers : Hématologie Hôpital Jean Bernard

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Poitiers : University Hospital

STI571 ProspectIve RandomIzed Trial: SPIRIT

Pontoise : Centre Hospitalier Rene Dubos

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pontoise :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Pringy : Ch de La Region D'Annecy

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Reims : Hopital Robert Debre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Reims :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Reims : CHU Robert Debré

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Reims : Hématologie pédiatrique-Hopital américain

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Rennes : Investigational Site Number 250004

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Rennes : Chru Hopital Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rennes : Hopital de Pontchaillou

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rennes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Rennes : CHU Pontchaillou

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Rennes : Service d'hématologie pédiatrique - Hôpital Sud

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Roubaix :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Rouen :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Rouen : CLCC H Becquerel Hematology

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Rouen : Centre Henri Becquerel

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rouen :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Rouen : Centre Henri Becquerel

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Rouen : Stephane LEPRETRE

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Rouen : CRLCC Henri Becquerel

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Rouen : Service d'Immuno Hémato Oncologie Pédiatrique - Hôpital Charles Nicolle

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Rouen Cedex : Investigational Site Number 250005

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Saint Brieuc :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Saint Etienne : Chu Hopital Nord

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Saint Etienne : Institut de Cancérologie de la Loire

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Saint Etienne : Hématologie, Oncologie pédiatrique-CHU Saint Etienne

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Saint Priest En Jarez : Institut Cancerologie de La Loire

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Saint Priest en Jarez Cedex : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Saint Quentin :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Saint-Cloud : Centre René Huguenin

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Saint-priest-en-jarez :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Saint-Quentin : CH Saint-Quentin

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Salon de Provence :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Salouel :

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Salouel :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

St Germain En Laye :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

St Herblain :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

St Priest en Jarez : Institut de Cancerologie de la Loire

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Strasbourg : Hopital de Hautepierre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Strasbourg :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Strasbourg : CHU Hautepierre

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Strasbourg : Hôpital Haute Pierre et Hôpital Civil

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Strasbourg : Chu-Strasbourg-Hopital Civil

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Strasbourg : Pédiatrie Hôpital Hautepierre

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Strasbourg : CHU Hautepierre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Toulon :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Toulouse : Hopital de Purpan

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Toulouse : Chu de Toulouse Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Toulouse :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Toulouse : CHU de Purpan

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Toulouse :

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Toulouse : 1208 - CHU de Purpan

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Toulouse : CHU Purpan

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Toulouse : CHU Purpan

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Toulouse : Hôpital Purpan

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Toulouse : Hopital des enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Toulouse : Service d'hematologie- Hopital Purpan- CHU de Toulouse

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Toulouse Cedex 9 : 1270.1.33003 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Toulouse cedex 9 : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Tours :

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tours : Hopital Bretonneau

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Tours :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Tours : CHU Bretonneau

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Tours : CHU- Centre Gatien de Clocheville

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Tours Cedex : Hopital Bretonneau

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Troyes :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Valence :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Valenciennes : Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Valenciennes : CH Valenciennes

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Vandoeuvre : Nancy University Hospital - Hôpitaux de Brabois

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Vandoeuvre Les Nancy : Hopital de Brabois

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Vandoeuvre Les Nancy : Hopital Brabois Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Vandoeuvre Les Nancy : CHU Brabois

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Vandoeuvre Les Nancy : CHU de Nancy Hôpitaux de Brabois

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Vandoeuvre les Nancy : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).

Vandoeuvre Les Nancy : Hôpital d'enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Vandoeuvre-les-nancy :

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Vandoeuvre-Les-Nancy : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Villejuif :

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Villejuif Cedex : Investigational Site Number 250003

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Germany

Aachen : Universitätsklinikum Aachen, AÖR, Site #513 Updated

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)